rolipram has been researched along with Cell Transformation, Neoplastic in 2 studies
Cell Transformation, Neoplastic: Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kowalczyk, P | 1 |
| Kinjo, T | 1 |
| Kowalczyk, M | 1 |
| Walaszek, Z | 1 |
| Hanausek, M | 1 |
| Slaga, TJ | 1 |
| Marko, D | 1 |
| Romanakis, K | 1 |
| Zankl, H | 1 |
| Fürstenberger, G | 1 |
| Steinbauer, B | 1 |
| Eisenbrand, G | 1 |
2 other studies available for rolipram and Cell Transformation, Neoplastic
| Article | Year |
|---|---|
Effect of phosphodiesterase antagonists on glucocorticoid mediated growth inhibition in murine skin cell lines.
Topics: Animals; Carcinoma, Squamous Cell; Cell Line; Cell Line, Tumor; Cell Transformation, Neoplastic; Dos | 2009 |
Induction of apoptosis by an inhibitor of cAMP-specific PDE in malignant murine carcinoma cells overexpressing PDE activity in comparison to their nonmalignant counterparts.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenine; Animals; Carcinoma; Cell Cycle; Cell Division; Cell Si | 1998 |